PDA announced the availability of "Medicine and vaccine shortages: What is the role of global regulatory complexity for post approval changes?", a report by The Economist Intelligence Unit that was commissioned by PDA. https://t.co/nUzxMaBvOl
Scaling out instead for scaling up: continuous bioprocessing gives the flexibility needed to deliver high quality products to all patients who need them - Gorazd Hribar, Novartis #PDAANNUAL